Impaired gamma interferon production by cells from patients with lymphoproliferative disorders of mature T and NK cells. 1985

F Pandolfi, and M Capobianchi, and P Matricardi, and J Facchini, and G Bonomo, and G De Rossi, and G Semenzato, and M Fiorilli, and F Dianzani, and F Aiuti

We investigated interferon (IFN) production by peripheral blood mononuclear cells from four patients with chronic OKT4 T-lymphocytic leukaemia and three patients with abnormal expansions of granular lymphocytes. No spontaneous production of IFN-gamma was found in supernatants of cultures from both patients and normal controls. However, whereas the enzyme galactose oxidase or staphylococcal enterotoxin B was able to induce IFN-gamma production by normal cells, no production could be obtained in the cells under study. The possibility that this lack of production might have been attributed to an excess of N-acetylneuraminic acid masking galactose residues or to a defect of monocyte accessory cells was ruled out either by pre-treating the cells with neuraminidase or by adding normal adherent cells to the cultures, both of which resulted in a lack of production. On the contrary, the calcium ionophore A23187 (considered to act as a second specific step, following oxidation of galactose residues, toward genetic derepression of IFN-gamma) induced considerable IFN-gamma production in all the three tested patients. It can be concluded that, although in rare cases, as previously reported by other authors, cells from patients with T or NK lymphoproliferative disorders may spontaneously produce IFN-gamma, this is not a general mechanism that underlies the disease. In fact, in all our cases a defect of IFN-gamma production was found. This defect seems due to an alteration at the membrane level of the galactose-containing glycoproteins and can be restored by induction with a calcium ionophore.

UI MeSH Term Description Entries
D007370 Interferon Type I Interferon secreted by leukocytes, fibroblasts, or lymphoblasts in response to viruses or interferon inducers other than mitogens, antigens, or allo-antigens. They include alpha- and beta-interferons (INTERFERON-ALPHA and INTERFERON-BETA). Interferons Type I,Type I Interferon,Type I Interferons,Interferon, Type I,Interferons, Type I
D007371 Interferon-gamma The major interferon produced by mitogenically or antigenically stimulated LYMPHOCYTES. It is structurally different from TYPE I INTERFERON and its major activity is immunoregulation. It has been implicated in the expression of CLASS II HISTOCOMPATIBILITY ANTIGENS in cells that do not normally produce them, leading to AUTOIMMUNE DISEASES. Interferon Type II,Interferon, Immune,gamma-Interferon,Interferon, gamma,Type II Interferon,Immune Interferon,Interferon, Type II
D007476 Ionophores Chemical agents that increase the permeability of biological or artificial lipid membranes to specific ions. Most ionophores are relatively small organic molecules that act as mobile carriers within membranes or coalesce to form ion permeable channels across membranes. Many are antibiotics, and many act as uncoupling agents by short-circuiting the proton gradient across mitochondrial membranes. Ionophore
D007694 Killer Cells, Natural Bone marrow-derived lymphocytes that possess cytotoxic properties, classically directed against transformed and virus-infected cells. Unlike T CELLS; and B CELLS; NK CELLS are not antigen specific. The cytotoxicity of natural killer cells is determined by the collective signaling of an array of inhibitory and stimulatory CELL SURFACE RECEPTORS. A subset of T-LYMPHOCYTES referred to as NATURAL KILLER T CELLS shares some of the properties of this cell type. NK Cells,Natural Killer Cells,Cell, NK,Cell, Natural Killer,Cells, NK,Cells, Natural Killer,Killer Cell, Natural,NK Cell,Natural Killer Cell
D007945 Leukemia, Lymphoid Leukemia associated with HYPERPLASIA of the lymphoid tissues and increased numbers of circulating malignant LYMPHOCYTES and lymphoblasts. Leukemia, Lymphocytic,Lymphocytic Leukemia,Lymphoid Leukemia,Leukemias, Lymphocytic,Leukemias, Lymphoid,Lymphocytic Leukemias,Lymphoid Leukemias
D008218 Lymphocytosis Excess of normal lymphocytes in the blood or in any effusion. Lymphocytoses
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D009000 Monocytes Large, phagocytic mononuclear leukocytes produced in the vertebrate BONE MARROW and released into the BLOOD; contain a large, oval or somewhat indented nucleus surrounded by voluminous cytoplasm and numerous organelles. Monocyte
D002118 Calcium A basic element found in nearly all tissues. It is a member of the alkaline earth family of metals with the atomic symbol Ca, atomic number 20, and atomic weight 40. Calcium is the most abundant mineral in the body and combines with phosphorus to form calcium phosphate in the bones and teeth. It is essential for the normal functioning of nerves and muscles and plays a role in blood coagulation (as factor IV) and in many enzymatic processes. Coagulation Factor IV,Factor IV,Blood Coagulation Factor IV,Calcium-40,Calcium 40,Factor IV, Coagulation

Related Publications

F Pandolfi, and M Capobianchi, and P Matricardi, and J Facchini, and G Bonomo, and G De Rossi, and G Semenzato, and M Fiorilli, and F Dianzani, and F Aiuti
February 1986, Scandinavian journal of immunology,
F Pandolfi, and M Capobianchi, and P Matricardi, and J Facchini, and G Bonomo, and G De Rossi, and G Semenzato, and M Fiorilli, and F Dianzani, and F Aiuti
November 1995, Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research,
F Pandolfi, and M Capobianchi, and P Matricardi, and J Facchini, and G Bonomo, and G De Rossi, and G Semenzato, and M Fiorilli, and F Dianzani, and F Aiuti
May 1996, The Journal of experimental medicine,
F Pandolfi, and M Capobianchi, and P Matricardi, and J Facchini, and G Bonomo, and G De Rossi, and G Semenzato, and M Fiorilli, and F Dianzani, and F Aiuti
February 1996, European journal of clinical investigation,
F Pandolfi, and M Capobianchi, and P Matricardi, and J Facchini, and G Bonomo, and G De Rossi, and G Semenzato, and M Fiorilli, and F Dianzani, and F Aiuti
January 2001, Hematology. American Society of Hematology. Education Program,
F Pandolfi, and M Capobianchi, and P Matricardi, and J Facchini, and G Bonomo, and G De Rossi, and G Semenzato, and M Fiorilli, and F Dianzani, and F Aiuti
August 1996, Clinical and experimental immunology,
F Pandolfi, and M Capobianchi, and P Matricardi, and J Facchini, and G Bonomo, and G De Rossi, and G Semenzato, and M Fiorilli, and F Dianzani, and F Aiuti
April 1985, Blood,
F Pandolfi, and M Capobianchi, and P Matricardi, and J Facchini, and G Bonomo, and G De Rossi, and G Semenzato, and M Fiorilli, and F Dianzani, and F Aiuti
April 1991, European journal of immunology,
F Pandolfi, and M Capobianchi, and P Matricardi, and J Facchini, and G Bonomo, and G De Rossi, and G Semenzato, and M Fiorilli, and F Dianzani, and F Aiuti
April 1992, Cellular immunology,
F Pandolfi, and M Capobianchi, and P Matricardi, and J Facchini, and G Bonomo, and G De Rossi, and G Semenzato, and M Fiorilli, and F Dianzani, and F Aiuti
January 2009, Oncology reports,
Copied contents to your clipboard!